A non-transmissible live attenuated SARS-CoV-2 vaccine

Live attenuated vaccines (LAVs) administered via the mucosal route may offer better control of the COVID-19 pandemic than non-replicating vaccines injected intramuscularly. Conceptionally, LAVs have several advantages, including presentation of the entire antigenic repertoire of the virus, and the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Julia M., Martin Vidal, Ricardo, Voß, Anne, Kunder, Sandra, Nascimento, Mariana, Abdelgawad, Azza, Langner, Christine, Vladimirova, Daria, Osterrieder, Nikolaus, Gruber, Achim D., Kunec, Dusan, Trimpert, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214529/
https://www.ncbi.nlm.nih.gov/pubmed/37263272
http://dx.doi.org/10.1016/j.ymthe.2023.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214529/
https://www.ncbi.nlm.nih.gov/pubmed/37263272
http://dx.doi.org/10.1016/j.ymthe.2023.05.004

Ejemplares similares